UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer

BMC cancer, 2016-06, Vol.16 (1), p.368-368, Article 368

2016

Volltextzugriff (PDF)

A Pilot Study of Taste Changes Among Hospice Inpatients With Advanced Cancer

American journal of hospice & palliative medicine, 2011-11, Vol.28 (7), p.487-492

2011

Volltextzugriff (PDF)

A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant

SAGE open medicine, 2018, Vol.6, p.2050312118800202-2050312118800202

2018

Volltextzugriff (PDF)

Treatments for metastatic hormone-sensitive prostate cancer: A systematic review

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.346-346

2018

Volltextzugriff (PDF)

Outcomes of immunotherapy in advanced melanoma in relation to age

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.187-187

2018

Volltextzugriff (PDF)

Hematology and oncology fellows' attitude and knowledge in cancer pain management

Journal of clinical oncology, 2015-10, Vol.33 (29_suppl), p.178-178

2015

Volltextzugriff (PDF)

Efficacy of immunotherapy in advanced melanoma: A network meta-analysis

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e21033-e21033

2016

Volltextzugriff (PDF)

Aggressive care at the end of life: A study of practice based factors in patients with stage IV cancer

Journal of clinical oncology, 2017-03, Vol.35 (8_suppl), p.80-80

2017

Volltextzugriff (PDF)

A novel prostate cancer immunotherapy using prostate specific antigen peptides and Candida skin test reagent as an immunostimulant

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14582-e14582

2016

Volltextzugriff (PDF)

Recurrence score distributions in stage II colon cancers of African American (AA) and Caucasian (CA) patients

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.613-613

2015

Volltextzugriff (PDF)

A novel prostate cancer immunotherapy using prostate-specific antigen peptides and skin test reagent as an adjuvant

SAGE open medicine, 2018-09, Vol.6

2018

Volltextzugriff (PDF)

Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors

Current oncology reports, 2021-09, Vol.23 (9), p.100-100, Article 100

2021

Volltextzugriff (PDF)

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma

OncoTargets and therapy, 2018-01, Vol.11, p.7095-7107

2018

Volltextzugriff (PDF)

Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma

The New England journal of medicine, 2015-10, Vol.373 (16), p.1580-1582

2015

Volltextzugriff (PDF)

Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors

Journal of oncology pharmacy practice, 2017-12, Vol.23 (8), p.620-624

2017

Volltextzugriff (PDF)

Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (6), p.1113-1123

2019

Volltextzugriff (PDF)

Indicators of responsiveness to immune checkpoint inhibitors

Scientific reports, 2017-04, Vol.7 (1), p.807-12, Article 807

2017

Volltextzugriff (PDF)

Neoadjuvant immunotherapy in clinical stage III melanoma: Real life experience in the community setting

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e21556-e21556

2024

Volltextzugriff (PDF)

Image Diagnosis: A Striking Bleomycin-Induced Skin Toxicity: Flagellate Hyperpigmentation

Permanente journal, 2017, Vol.21 (1), p.16

2017

Volltextzugriff (PDF)

Effectiveness of Cyanoacrylate in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection: A Randomized Controlled Trial

Frontiers in oncology, 2021-01, Vol.10, p.580861

2021

Volltextzugriff (PDF)

Established and potential therapeutic applications of cannabinoids in oncology

Supportive care in cancer, 2003-03, Vol.11 (3), p.137-143

2003

Volltextzugriff (PDF)

Absolute lymphocyte count (ALC) as predictor of Pneumocystis Jiroveci Pneumonia (PCP) infection in patients on immune checkpoint inhibitors (ICPi)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14255-e14255

2019

Volltextzugriff (PDF)

Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack

Cancer biology & therapy, 2017-07, Vol.18 (7), p.451-469

2017

Volltextzugriff (PDF)

Abstract 2037: E-cadherin enhances immune control of metastatic melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2037-2037

2018

Volltextzugriff (PDF)

The role of C-reactive protein as a prognostic indicator in advanced cancer

Current oncology reports, 2002-06, Vol.4 (3), p.250-255

2002

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(65)
Berichte
(2)

Sprache

Englisch
(67)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer

A Pilot Study of Taste Changes Among Hospice Inpatients With Advanced Cancer

A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant

Treatments for metastatic hormone-sensitive prostate cancer: A systematic review

Outcomes of immunotherapy in advanced melanoma in relation to age

Hematology and oncology fellows' attitude and knowledge in cancer pain management

Efficacy of immunotherapy in advanced melanoma: A network meta-analysis

Aggressive care at the end of life: A study of practice based factors in patients with stage IV cancer

A novel prostate cancer immunotherapy using prostate specific antigen peptides and Candida skin test reagent as an immunostimulant

Recurrence score distributions in stage II colon cancers of African American (AA) and Caucasian (CA) patients

A novel prostate cancer immunotherapy using prostate-specific antigen peptides and skin test reagent as an adjuvant

Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma

Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma

Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors

Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma

Indicators of responsiveness to immune checkpoint inhibitors

Neoadjuvant immunotherapy in clinical stage III melanoma: Real life experience in the community setting

Image Diagnosis: A Striking Bleomycin-Induced Skin Toxicity: Flagellate Hyperpigmentation

Effectiveness of Cyanoacrylate in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection: A Randomized Controlled Trial

Established and potential therapeutic applications of cannabinoids in oncology

Absolute lymphocyte count (ALC) as predictor of Pneumocystis Jiroveci Pneumonia (PCP) infection in patients on immune checkpoint inhibitors (ICPi)

Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack

Abstract 2037: E-cadherin enhances immune control of metastatic melanoma

The role of C-reactive protein as a prognostic indicator in advanced cancer

Suchergebnisse filtern